¿Aún no es miembro de TradeKey.com? Regístrese para conectarse con 9 millones de importadores y exportadores a nivel mundial.
registro |
BOOK A CALL
Book Call On Your Favorite Time

By Signing Up. I agree to TradeKey.com Terms of Use, Privacy Policy, IPR and receive emails related to our services

Contact Us
product
Prev
Dia-cope
Next

Dia-cope

|

- Minimum Order

País:

China

N º de Modelo:

-

Precio FOB:

Lugar de origen:

-

Precio de pedido mínimo:

-

Cantidad de pedido mínimo:

-

Detalle de embalaje:

-

El tiempo de entrega:

-

Capacidad de suministro:

-

Tipo de pago:

-

Grupo de productos :

-

Contactar ahora

Persona de contacto Danyang

Chongqing, Chongqing

Contactar ahora

Especificaciones del producto

  • Natural Hypoglycemic Product :Dia-cope Hypoglycemic Capsule

Descripción del producto

Beijing Standard Health & Technology Co., Ltd. has set up strategic relations with Sagee US, becoming the one and only agent for Asia Star Dia-cope Capsule in China. Now we are bringing it to benefit the Chinese people.

Studies from experts in Modern Biological Research Centre, Bastry University of US have shown that Alaska is the right place to grow onions. Because its average temperature throughout the year is between ***5℃, with long duration of sunshine, sharp variation in temperature. Compared to onions from other places, onions from Alaska contain more natural hypoglycemic elements. Using MAE technology, Dia-cope is made by extracts like hypoglycemic factor, para-insulin, GTF, vitamin P from Alaska onions, bitter melon seeds, pumpkin seeds, and bitter buckwheat. It is mass-produced by US GMPpharmaceutical factory, and approved by FDA. After 3 years animal and human trial, it is approved by SFDA as the imported health care product that can help lower blood-sugar level. The registered number of approval is: J*******4. No country in the world except America has the ability to extract effective ingredients from a plant, which makes Dia-cope a high-tech biological product with American patent.

With the latest bio-technology, Dia-cope can lower, stabilize, and control blood glucose, without fluctuate the patients index. The raw materials are from all natural herbal essence with no trace of western medicine. Combined with the high-tech extraction process, Dia-cope can improve the patients self-healing ability, so its safe and reliable with no toxic or side effects. The hypoglycemic factor in Dia-cope can reduce blood glucose biologically. After intake it will selectively protect, repair, and activateβ islet cells, stimulate secretion of insulin, and revive its function. Thus it solves the problem of insulin resistance. GTF can further stimulate the effect of exogenous insulin, and improve sugar tolerance, lower the density and improve the sensitivity of plasma insulin.

Patients, who have been taking hypoglycemic medicines for a long time, also have the medical toxicity inside their body increased. It not only does harm to organs, but also burdens the metabolism of glucose. By using Dia-cope, the patients hepatorenal channel is opened up and cleaned, because the vitamin P contained is good for the metabolism. It quickly wipes off the medical toxicity attached on the surface of viscera cells, and discharged in the way of hepatorenal metabolism. In this way the damage by toxicity is stopped, and Qi and blood are unblocked. As a result, the body is like an empty cup, metabolic and absorptive ability are enhanced, nutrients and medicines can be better absorbed, so as to achieve better treating result with half the effort.

Dia-cope contains organic acid, alkaloid, hypoglycemic factors, they directly affect patients blood and immune system, lower glucose, blood lipid, blood viscosity, eliminate oxygen radical, repair vascular wall damage , improve micro-circulation, unblock bloodstream, provide sufficient nutrients to organs viscera cell, greatly prevent complications with cardiovascular and cerebrovascular diseases, hepatic lesions, and fundus lesions, to finally get full recovery.

Dia-Cope has passed the clinical trial of *1 national level*3 hospitals. With the average reduction of medicine by *2%, and based on ***7 clinical reports, **3 patients have fully recovered, ***6 patients have stabilized blood glucose and diabetic symptoms, **7 have slightly improved, thus the total effective rates have reached *8.8%.  

País: China
N º de Modelo: -
Precio FOB: Obtener el precio más reciente
Lugar de origen: -
Precio de pedido mínimo: -
Cantidad de pedido mínimo: -
Detalle de embalaje: -
El tiempo de entrega: -
Capacidad de suministro: -
Tipo de pago: -
Grupo de productos : -

Productos relacionados Beijing Standard Health Technology Co., Ltd.

Send a direct inquiry to this supplier

A:

Danyang < Beijing Standard Health Technology Co., Ltd. >

quiero saber: